PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-40.37%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
4.11%
Positive gross profit growth while 0354.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
331.61%
Operating income growth above 1.5x 0354.HK's 34.84%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
122.84%
Net income growth above 1.5x 0354.HK's 12.08%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
123.08%
EPS growth above 1.5x 0354.HK's 7.69%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
123.08%
Diluted EPS growth above 1.5x 0354.HK's 8.33%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-1.87%
Share reduction while 0354.HK is at 2.52%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.87%
Reduced diluted shares while 0354.HK is at 2.04%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-52.62%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-52.45%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-28.92%
Negative 10Y revenue/share CAGR while 0354.HK stands at 362.43%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-28.39%
Negative 5Y CAGR while 0354.HK stands at 138.65%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
5.64%
3Y revenue/share CAGR under 50% of 0354.HK's 63.71%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
782.75%
Positive long-term OCF/share growth while 0354.HK is negative. John Neff would see a structural advantage in sustained cash generation.
157.26%
Positive OCF/share growth while 0354.HK is negative. John Neff might see a comparative advantage in operational cash viability.
104.13%
Positive 3Y OCF/share CAGR while 0354.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-68.71%
Negative 10Y net income/share CAGR while 0354.HK is at 435.10%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-46.68%
Negative 5Y net income/share CAGR while 0354.HK is 237.39%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-57.80%
Negative 3Y CAGR while 0354.HK is 108.67%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
6.34%
Below 50% of 0354.HK's 80.02%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.80%
Negative 3Y equity/share growth while 0354.HK is at 49.57%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0354.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0354.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-37.69%
Firm’s AR is declining while 0354.HK shows 22.46%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-50.48%
Inventory is declining while 0354.HK stands at 35.65%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-41.20%
Negative asset growth while 0354.HK invests at 2.25%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.14%
Under 50% of 0354.HK's 5.19%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-70.86%
We’re deleveraging while 0354.HK stands at 13.16%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-33.26%
We cut SG&A while 0354.HK invests at 35.48%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.